NEW YORK (TheStreet) -- RATINGS CHANGES
Allergan (AGN - Get Report) was downgraded at Credit Suisse to neutral from outperform. Twelve-month price target is $190. Risk/reward is balanced, following the latest bid from Valeant (VRX), Credit Suisse said.
Big Lots (BIG) was downgraded to hold at TheStreet Ratings.
Broadcom (BRCM) was downgraded at Stifel to hold from buy, Stifel Nicolaus said. Valuation call, based on a 12-month price target of $35, Stifel Nicolaus said.
Broadcom was upgraded at Wedbush to outperform from neutral. Twelve-month price target is $43. Company is looking to sell or wind down the cellular baseband business, which has been an overhang, Wedbush said.
Chico's FAS (CHS) was downgraded to hold at TheStreet Ratings.
Centene (CNC) was downgraded at Citigroup to sell. Takeover rumors will likely fizzle out, Citi said.
Devon Energy (DVN) was upgraded at Wells Fargo to outperform from market perform. Production visibility is improving, Wells Fargo said.
Editor's note: To see analysts' stock comments and changes to price targets and earnings estimates, go to "Street Notes" which is available only to Real Money subscribers. To find out how to become a subscriber, please click here.
>>Read More: Greenberg: Apple's Latest Ad-Stravaganza